| Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients E Papadopoulou, N Tsoulos, K Tsantikidi, V Metaxa-Mariatou, PE Stamou, ... PloS one 14 (12), e0226853, 2019 | 52 | 2019 |
| The role of exosomal non-coding RNAs in colorectal cancer drug resistance DI Lampropoulou, E Pliakou, G Aravantinos, D Filippou, M Gazouli International journal of molecular sciences 23 (3), 1473, 2022 | 22 | 2022 |
| MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil FD Pouya, M Gazouli, Y Rasmi, DI Lampropoulou, M Nemati Molecular Biology Reports 49 (6), 5165-5178, 2022 | 12 | 2022 |
| MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer DI Lampropoulou, G Aravantinos, K Laschos, T Theodosopoulos, ... International Journal of Colorectal Disease 34, 1871-1877, 2019 | 12 | 2019 |
| Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer DI Lampropoulou, G Aravantinos, H Katifelis, F Lazaris, K Laschos, ... Cancer Biomarkers 25 (2), 213-221, 2019 | 12 | 2019 |
| Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate … DI Lampropoulou, K Laschos, AL Amylidi, A Angelaki, N Soupos, ... Journal of Oncology Pharmacy Practice 26 (3), 747-753, 2020 | 11 | 2020 |
| First line gemcitabine/pazopanib in locally advanced and/or metastatic biliary tract carcinoma. A Hellenic Cooperative Oncology Group Phase II Study J Sgouros, G Aravantinos, GA Koliou, G Pentheroudakis, F Zagouri, ... Anticancer Research 40 (2), 929-938, 2020 | 7 | 2020 |
| Circulating miRNA expression profiles and machine learning models in association with response to irinotecan-based treatment in metastatic colorectal cancer E Pliakou, DI Lampropoulou, N Dovrolis, D Chrysikos, D Filippou, ... International Journal of Molecular Sciences 24 (1), 46, 2022 | 6 | 2022 |
| Skin metastases from gastric cancer, a rare entity masquerading as erysipelas: A case report E Pliakou, DI Lampropoulou, D Nasi, G Aravantinos Molecular and Clinical Oncology 16 (6), 1-4, 2022 | 5 | 2022 |
| The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection DI Lampropoulou, VM Bala, E Zerva, E Pliakou, D Filippou, M Gazouli, ... The Journal of Infection in Developing Countries 16 (01), 101-111, 2022 | 5 | 2022 |
| Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope? K Laschos, DI Lampropoulou, G Aravantinos, M Piperis, D Filippou, ... World journal of gastrointestinal surgery 12 (10), 407, 2020 | 5 | 2020 |
| Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer VM Bala, DI Lampropoulou, S Grammatikaki, V Kouloulias, N Lagopati, ... International Journal of Molecular Sciences 25 (1), 296, 2023 | 4 | 2023 |
| Mediastinal and hilar sarcoid‑like reaction in a patient treated with dabrafenib and trametinib for metastatic melanoma: A case report and review of the literature VM Bala, M Mitsogianni, K Laschos, E Pliakou, E Lazaridi, ... Molecular and Clinical Oncology 16 (5), 1-5, 2022 | 4 | 2022 |
| Association between homeobox protein transcript antisense intergenic ribonucleic acid genetic polymorphisms and cholangiocarcinoma DI Lampropoulou, K Laschos, G Aravantinos, K Georgiou, K Papiris, ... World Journal of Clinical Cases 9 (8), 1785, 2021 | 4 | 2021 |
| The Role of EMT-Related lncRNAs in Ovarian Cancer DI Lampropoulou, M Papadimitriou, C Papadimitriou, D Filippou, ... International Journal of Molecular Sciences 24 (12), 10079, 2023 | 3 | 2023 |
| Synchronous gastric adenocarcinoma and diffuse large B-cell lymphoma in the pelvis: A rare case presentation E Pliakou, DI Lampropoulou, N Soupos, G Aravantinos Case Reports in Gastrointestinal Medicine 2022, 2022 | 3 | 2022 |
| Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study) M Liontos, E Timotheadou, EI Papadopoulos, Z Zafeiriou, ... Current Oncology 28 (6), 5266-5277, 2021 | 2 | 2021 |
| CDK4/6 Inhibitors and SSRIs/SNRIs: A Brief Review of Their Safety Profiles Focusing on Potential Drug Interactions DI Lampropoulou, K Lioliou, E Zerva, X Madia, D Vardoulaki, ... Top. Biomed. Res. Educ 1, 24-32, 2023 | 1 | 2023 |
| Immune-related dermatologic toxicities: to make a long story short A Angelaki, DI Lampropoulou, G Aravantinos Cutaneous and Ocular Toxicology 39 (1), 10-12, 2020 | 1 | 2020 |
| Diving Medicine: An Exciting Journey Through Time and Future Prospects DI Lampropoulou, D Papageorgiou, E Pliakou Cureus 16 (3), 2024 | | 2024 |
Maria GazouliSchool of Medicine, National and Kapodistrian University of Athens, GreeceΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα med.uoa.gr
